×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Experiment: Selective Vulnerability of Dopaminergic Neurons — Mechanism
experiment
1,060 words
KG: PD
2026-03-26
kind:experiment
section:experiments
state:published
disease:parkinsons
Contents
Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protection
Knowledge Graph
Related Hypotheses (22)
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
APOE-Dependent Autophagy Restoration
Score: 0.61
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Microbial Inflammasome Priming Prevention
Score: 0.58
PARP1 Inhibition Therapy
Score: 0.58
Smartphone-Detected Motor Variability Correction
Score: 0.56
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.48
Arginine Methylation Enhancement Therapy
Score: 0.46
HDAC3-Selective Inhibition for Clock Reset
Score: 0.46
Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.44
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.43
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.41
Mitochondrial Calcium Buffering Enhancement via MCU Modulati
Score: 0.38
Show 17 more
Related Analyses (20)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · completed
Show 15 more
Related Experiments (16)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40
Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90
Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85
Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85
Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85
Spatial transcriptomic analysis of multistage ESCC developme
exploratory · proposed · Score: 0.85
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
Functional analysis of EFNB1-EPHB4 interaction in EMT
exploratory · proposed · Score: 0.80
Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr
exploratory · proposed · Score: 0.75
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Show 11 more
See Also (15)
LRRK2 G2019S Transgenic Mouse Model
model · KG edge: causes
Age-Sensitive Cortical Vulnerability in Parkinson's Dis
mechanism · KG edge: associated_with
MCL1 Gene - Myeloid Cell Leukemia 1
gene · KG edge: implicated_in
IDH1 Gene - Isocitrate Dehydrogenase 1
gene · KG edge: implicated_in
eef1a1
gene · KG edge: implicated_in
DOT1L Gene
gene · KG edge: implicated_in
CNTNAP4 Gene
gene · KG edge: associated_with
APOB Gene
gene · KG edge: implicated_in
ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: implicated_in
DNA Damage Repair Deficiency Validation Study in Parkin
experiment · KG edge: implicated_in
GBA1 (Redirect)
redirect · KG edge: causes
ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 3 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 3 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 3 hypotheses
Show 10 more
Knowledge Graph (12 edges)
PD
causes
NEURODEGENERATION
PD
causes
DOPAMINERGIC_NEURONS
PD
causes
neurodegeneration
PD
contributes_to
synucleinopathies
PD
associated_with
DEPRESSION
PD
associated_with
T2DM
NEUROINFLAMMATION
contributes_to
PD
NEUROTROPHINS
treats
PD
AGE
associated_with
PD
SNCA
causes
PD